Please login to the form below

Not currently logged in
Email:
Password:

Bayer Healthcare's Mark Trudeau joins Covidien

New head of pharmaceuticals will lead division’s efforts to become a standalone company

Mark Trudea - CovidienBayer's Mark Trudeau is to take over as president of Covidien's pharmaceutical segment as senior vice president.

Trudeau, who serves as president and CEO of Bayer Healthcare Pharmaceuticals US Region, will assume his new role on February 1.

He replaces Matthew Harbaugh, chief financial officer, pharmaceuticals, who has served as interim president since Timothy Wright resigned in November 2010. Harbaugh will continue as chief financial officer.

In his new role, Trudeau will oversee plans to turn Covidien's pharmaceutical division into its own standalone company, announced in December, 2011 and expected to be completed by the middle of 2013.

Covidien, which has headquarters in both Ireland and the US, is currently ranked among the top 10 generic drug manufacturers in the US.

Trudeau has spent over 25 years' experience in the pharmaceutical industry, including several years at Bristol-Myers Squibb (BMS) before joining Bayer.

His roles at BMS included vice president and general manager of the company's immunology division and regional president, Asia-Pacific.

He has also worked at Eli Lilly & Company and Abbott Laboratories, and serves on the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) and the board of trustees of the HealthCare Institute of New Jersey.

17th January 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics